View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 9, 2022

Medable unveils partner network to expedite decentralised trial deployment

The Medable Partner Network permits sponsors to mount their approaches to put patients at the centre of care.

Medable has introduced the Medable Partner Network, combining a varied ecosystem of technology, service, data, site, and direct-to-patient partners that collaborate to expedite decentralised clinical trial deployment. 

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The network comprises new collaborations with Advanced Clinical, Cognizant and CVS, as well as extended partnerships with Datavant, Parexel, Oracle, Thermo Fisher Scientific’s PPD and Syneos Health. 

These collaborators share Medable’s goal of delivering efficient treatments to patients quickly.

To be successful, pharma and biotech sponsors require scalability, quicker time to market, reduced operating expenses and new technology and service partners, the company noted.

Medable aids sponsors to build, introduce and manage trials based on an established clinical trials platform, adaptable applications, expanded partner ecosystem and round the clock worldwide support.

Leveraging remote trial access, user experiences and various services, connected devices and data sources, the Medable Partner Network permits sponsors to mount their approaches to put patients at the centre of care.

The network categories comprise service partners, data partners, technology partners, direct-to-patient partners and site partners.

Medable chief strategy officer MaryAnne Rizk said: “The next stage of clinical trial transformation is collaboration at scale. 

“Accelerating innovation requires an ecosystem, so we’ve created the Medable Partner Network to simplify collaboration for both sponsors and partners. 

“Our ecosystem of certified partners allows us to innovate faster together, so we can deliver smarter trials to meet the needs of patients and address the biggest challenges in healthcare.”

The latest development comes after Medable and CVS Health signed a partnership to expand access and engagement to trials for patients at chosen MinuteClinic locations using the former’s clinical trials software platform. 

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena